Zobrazeno 1 - 10
of 143
pro vyhledávání: '"MH Abreu"'
Autor:
FL Figueroa, J Bonomi Barufi, EJ Malta, R Conde-Álvarez, U Nitschke, F Arenas, M Mata, S Connan, MH Abreu, R Marquardt, F Vaz-Pinto, T Konotchick, PSM Celis-Plá, M Hermoso, G Ordoñez, E Ruiz, P Flores, J de los Ríos, D Kirke, F Chow, CAG Nassar, D Robledo, Á Pérez-Ruzafa, E Bañares-España, M Altamirano, C Jiménez, N Korbee, K Bischof, DB Stengel
Publikováno v:
Aquatic Biology, Vol 22, Pp 177-193 (2014)
Short-term effects of increasing pCO2; 380 ppm (LC) vs. 700 ppm (HC); at different nitrogen levels; 5 µM nitrate (LN) vs. 50 µM (HN); on the contents of protein, mycosporine-like amino acids (MAAs), phenolic compounds and total fatty acids, antioxi
Externí odkaz:
https://doaj.org/article/29683003adad46a4b271f952869deb51
Autor:
Almeida-Nunes DL; Differentiation and Cancer Group, Institute for Research and Innovation in Health (i3S) of the University of Porto, 4200-135, Porto, Portugal.; Associate Laboratory I4HB, Institute for Health and Bioeconomy, University Institute of Health Sciences-CESPU, 4585-116, Gandra, Portugal.; UCIBIO-Applied Molecular Biosciences Unit, Toxicologic Pathology Research Laboratory, University Institute of Health Sciences (1H-TOXRUN, IUCS-CESPU), 4585-116, Gandra, Portugal., Nunes M; Differentiation and Cancer Group, Institute for Research and Innovation in Health (i3S) of the University of Porto, 4200-135, Porto, Portugal.; Associate Laboratory I4HB, Institute for Health and Bioeconomy, University Institute of Health Sciences-CESPU, 4585-116, Gandra, Portugal.; UCIBIO-Applied Molecular Biosciences Unit, Toxicologic Pathology Research Laboratory, University Institute of Health Sciences (1H-TOXRUN, IUCS-CESPU), 4585-116, Gandra, Portugal.; School of Medicine and Biomedical Sciences (ICBAS), University of Porto, 4050-313, Porto, Portugal., Osório H; Proteomics Scientific Platform, Institute for Research and Innovation in Health (i3S) of the University of Porto, 4200-135, Porto, Portugal.; Department of Pathology, Faculty of Medicine from University of Porto (FMUP), 4200-319, Porto, Portugal., Ferreira V; Department of Pathology, Portuguese Oncology Institute of Porto (IPO-Porto), 4200-072, Porto, Portugal., Lobo C; Department of Pathology, Portuguese Oncology Institute of Porto (IPO-Porto), 4200-072, Porto, Portugal., Monteiro P; Department of Pathology, Portuguese Oncology Institute of Porto (IPO-Porto), 4200-072, Porto, Portugal., Abreu MH; Department of Medical Oncology, Portuguese Oncology Institute of Porto (IPO-Porto), 4200-072, Porto, Portugal.; Porto Comprehensive Cancer Center Raquel Seruca (PCCC), Portuguese Oncology Institute of Porto (IPO-Porto), 4200-072, Porto, Portugal., Bartosch C; Department of Pathology, Portuguese Oncology Institute of Porto (IPO-Porto), 4200-072, Porto, Portugal.; Porto Comprehensive Cancer Center Raquel Seruca (PCCC), Portuguese Oncology Institute of Porto (IPO-Porto), 4200-072, Porto, Portugal.; Cancer Biology & Epigenetics Group, Research Center of Portuguese Oncology Institute of Porto (CI-IPO-Porto) / Health Research Network (RISE@CI-IPO-Porto), Portuguese Oncology Institute of Porto (IPO-Porto), 4200-072, Porto, Portugal., Silvestre R; Life and Health Sciences Research Institute (ICVS), School of Medicine from University of Minho, 4710-057, Braga, Portugal.; ICVS/3B's - PT Government Associate Laboratory, 4710-057, Braga/Guimarães, Portugal., Dinis-Oliveira RJ; Associate Laboratory I4HB, Institute for Health and Bioeconomy, University Institute of Health Sciences-CESPU, 4585-116, Gandra, Portugal.; Department of Public Health and Forensic Sciences and Medical Education, Faculty of Medicine, University of Porto, 4200-319, Porto, Portugal.; UCIBIO - Research Unit on Applied Molecular Biosciences, Translational Toxicology Research Laboratory, University Institute of Health Sciences (1H-TOXRUN, IUCS-CESPU), 4585-116, Gandra, Portugal.; FOREN - Forensic Science Experts, Dr. Mário Moutinho Avenue, No. 33-A, 1400-136, Lisbon, Portugal., Ricardo S; Differentiation and Cancer Group, Institute for Research and Innovation in Health (i3S) of the University of Porto, 4200-135, Porto, Portugal.; Associate Laboratory I4HB, Institute for Health and Bioeconomy, University Institute of Health Sciences-CESPU, 4585-116, Gandra, Portugal.; UCIBIO-Applied Molecular Biosciences Unit, Toxicologic Pathology Research Laboratory, University Institute of Health Sciences (1H-TOXRUN, IUCS-CESPU), 4585-116, Gandra, Portugal.
Publikováno v:
Biochemistry and biophysics reports [Biochem Biophys Rep] 2024 Jun 13; Vol. 39, pp. 101755. Date of Electronic Publication: 2024 Jun 13 (Print Publication: 2024).
Autor:
Nunes M; Differentiation and Cancer Group, Institute for Research and Innovation in Health (i3S), University of Porto, 4200-135 Porto, Portugal.; Institute of Biomedical Sciences Abel Salazar (ICBAS), University of Porto, 4050-313 Porto, Portugal., Bartosch C; Porto Comprehensive Cancer Center Raquel Seruca (PCCC), Portuguese Oncology Institute of Porto (IPO-Porto), 4200-072 Porto, Portugal.; Department of Pathology, Portuguese Oncology Institute of Porto (IPO-Porto), 4200-072 Porto, Portugal.; Cancer Biology & Epigenetics Group, Research Center of Portuguese Oncology Institute of Porto (CI-IPO-Porto), Health Research Network (RISE@CI-IPO-Porto), Portuguese Oncology Institute of Porto (IPO-Porto), 4200-072 Porto, Portugal., Abreu MH; Porto Comprehensive Cancer Center Raquel Seruca (PCCC), Portuguese Oncology Institute of Porto (IPO-Porto), 4200-072 Porto, Portugal.; Department of Medical Oncology, Portuguese Oncology Institute of Porto (IPO-Porto), 4200-072 Porto, Portugal., Richardson A; The School of Pharmacy and Bioengineering, Guy Hilton Research Centre, Keele University, Thornburrow Drive, Stoke-on-Trent ST4 7QB, Staffordshire, UK., Almeida R; Differentiation and Cancer Group, Institute for Research and Innovation in Health (i3S), University of Porto, 4200-135 Porto, Portugal.; Biology Department, Faculty of Sciences, University of Porto (FCUP), 4169-007 Porto, Portugal.; Associate Laboratory i4HB, Institute for Health and Bioeconomy, University Institute of Health Sciences-CESPU, 4585-116 Gandra, Portugal., Ricardo S; Differentiation and Cancer Group, Institute for Research and Innovation in Health (i3S), University of Porto, 4200-135 Porto, Portugal.; Associate Laboratory i4HB, Institute for Health and Bioeconomy, University Institute of Health Sciences-CESPU, 4585-116 Gandra, Portugal.; UCIBIO-Applied Molecular Biosciences Unit, Toxicologic Pathology Research Laboratory, University Institute of Health Sciences (1H-TOXRUN, IUCS-CESPU), 4585-116 Gandra, Portugal.
Publikováno v:
Cells [Cells] 2024 May 04; Vol. 13 (9). Date of Electronic Publication: 2024 May 04.
Autor:
Tolaney SM; Dana-Farber Cancer Institute, Boston, MA, USA. Electronic address: Sara_Tolaney@DFCI.HARVARD.EDU., Guarneri V; Oncology2, Istituto Oncologico Veneto IRCCS, Padua, Italy., Seo JH; Korea University Guro Hospital, Seoul, Republic of Korea., Cruz J; Hospital Universitario de Canarias, Canary Islands, Spain., Abreu MH; Department of Medical Oncology, Portuguese Institute of Oncology of Porto, Porto, Portugal., Takahashi M; Department of Breast Surgery, Hokkaido University Hospital, Hokkaido, Japan., Barrios C; Latin American Cooperative Oncology Group (LACOG), Oncoclínicas, Porto Alegre, Brazil., McIntyre K; Texas Oncology PA, TX, USA., Wei R; Eli Lilly and Company, IN, USA., Munoz M; Eli Lilly and Company, IN, USA., Antonio BS; Eli Lilly and Company, IN, USA., Liepa AM; Eli Lilly and Company, IN, USA., Martin M; Hospital General Universitario Gregorio Marañon, Universidad Complutense, CIBERONC, GEICAM, Madrid, Spain., Johnston SRD; Royal Marsden NHS Foundation Trust, London, United Kingdom., Kellokumpu-Lehtinen PL; Tampere University Hospital Cancer Center, Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland., Harbeck N; Breast Centre, Department of Gynaecology and Obstetrics, Comprehensive Cancer Centre Munich, LMU University Hospital, Munich, Germany.
Publikováno v:
European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2024 Mar; Vol. 199, pp. 113555. Date of Electronic Publication: 2024 Jan 16.
Autor:
Teixeira AR; Oncology, Instituto Português de Oncologia, Porto, PRT., Abreu MH; Oncology, Instituto Português de Oncologia, Porto, PRT.
Publikováno v:
Cureus [Cureus] 2023 Nov 10; Vol. 15 (11), pp. e48626. Date of Electronic Publication: 2023 Nov 10 (Print Publication: 2023).
Autor:
Schröder CP; Department Medical Oncology, Netherlands Cancer Institute Amsterdam and University Medical Center Groningen, The Netherlands., van Leeuwen-Stok E; Dutch Breast Cancer Trialists' Research Group (BOOG), The Netherlands., Cardoso F; Breast Unit, Champalimaud Clinical Center/Champalimaud Foundation, Lisbon, Portugal., Linderholm B; Department of Oncologym, Sahlgrenska University Hospital, Gothenburg, Sweden and Swedish Association of Breast Oncologists (SABO), Sweden., Poncet C; European Organisation for Research and Treatment of Cancer (EORTC) Headquarters, Brussels, Belgium., Wolff AC; Department of Medical Oncology, Johns Hopkins, Baltimore, MD, USA., Bjelic-Radisic V; Breast Unit, Helios University Clinic, Wuppertal, University Witten/Herdecke, Germany., Werutsky G; Latin American Cooperative Oncology Group, Porto Alegre, Brazil., Abreu MH; Department of Medical Oncology, Portuguese Institute of Oncology of Porto, Porto, Portugal., Bozovic-Spasojevic I; Department of Medical Oncology, Institute of Oncology and Radiology, Belgrade, Serbia., den Hoed I; Department of Medical Oncology, Elisabeth-TweeSteden Ziekenhuis, Tilburg, The Netherlands., Honkoop AH; Department of Medical Oncology, Isala, Zwolle, The Netherlands., Los M; Department of Medical Oncology, St. Antonius Ziekenhuis, Utrecht, The Netherlands., Leone JP; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA., Russell NS; Department of Radiotherapy, Netherlands Cancer Institute - Antoni van Leeuwenhoek, Amsterdam, The Netherlands., Smilde TJ; Department of Medical Oncology, Jeroen Bosch Ziekenhuis's Hertogenbosch, The Netherlands., van der Velden AWG; Department of Medical Oncology, Martini Ziekenhuis, Groningen, The Netherlands., Van Poznak C; Department of Medical Oncology, University of Michigan, Ann Arbor, MI, USA., Vleugel MM; Department of Medical Oncology, Waterlandziekenhuis, Purmerend, The Netherlands., Yung RL; Department of Medical Oncology, University of Washington and Fred Hutchinson Cancer Research Center, Seattle, WA, USA., Coens C; European Organisation for Research and Treatment of Cancer (EORTC) Headquarters, Brussels, Belgium., Giordano SH; Department of Health Services Research and Department of Breast Medical Oncology, MD Anderson Cancer Center, Houston, TX, USA., Ruddy KJ; Department of Oncology, Mayo Clinic, Rochester, MN, USA.
Publikováno v:
The oncologist [Oncologist] 2023 Oct 03; Vol. 28 (10), pp. e877-e883.
Autor:
Paredes SO; Post-graduation Program in Dentistry. Federal University of Paraíba, João Pessoa, Paraíba, Brazil., de Lucena EH; Post-graduation Program in Dentistry. Federal University of Paraíba, João Pessoa, Paraíba, Brazil., Abreu MH; Federal University of Minas Gerais, Belo Horizonte, Minas Gerais, Brazil., Forte FD; Post-graduation Program in Dentistry. Federal University of Paraíba, João Pessoa, Paraíba, Brazil.
Publikováno v:
Journal of clinical and experimental dentistry [J Clin Exp Dent] 2023 Aug 01; Vol. 15 (8), pp. e658-e665. Date of Electronic Publication: 2023 Aug 01 (Print Publication: 2023).
Autor:
Abreu MH; Department of Medical Oncology, Portuguese Oncology Institute of Porto (IPO-Porto), Porto, Portugal.; Porto Comprehensive Cancer Center Raquel Seruca (PCCC), Porto, Portugal., Lillsunde-Larsson G; Department of Laboratory Medicine, Faculty of Medicine and Health, Örebro University, Örebro, Sweden.; School of Health Sciences, Örebro University, Örebro, Sweden., Bartosch C; Porto Comprehensive Cancer Center Raquel Seruca (PCCC), Porto, Portugal.; Department of Pathology, Portuguese Oncology Institute of Porto (IPO-Porto), Porto, Portugal.; Cancer Biology & Epigenetics Group, Research Center of Portuguese Oncology Institute of Porto (CI-IPO-Porto)/Health Research Network (RISE@CI-IPO-Porto), Portuguese Oncology Institute of Porto (IPO-Porto), Porto, Portugal., Ricardo S; Differentiation and Cancer Group, Institute for Research and Innovation in Health (i3S) of the University of Porto, Porto, Portugal.; 1H-TOXRUN - One Health Toxicology Research Unit, University Institute of Health Sciences (IUCS), CESPU, CRL, Gandra, Portugal.; Department of Pathology, Faculty of Medicine from University of Porto (FMUP), Porto, Portugal.
Publikováno v:
Frontiers in oncology [Front Oncol] 2023 Jun 21; Vol. 13, pp. 1235035. Date of Electronic Publication: 2023 Jun 21 (Print Publication: 2023).
Autor:
Marques F; CESAM-Centre for Environmental and Marine Studies, Department of Chemistry, University of Aveiro, Santiago University Campus, 3810-193 Aveiro, Portugal.; Mass Spectrometry Centre, LAQV-REQUIMTE, Department of Chemistry, University of Aveiro, Santiago University Campus, 3810-193 Aveiro, Portugal., Lopes D; CESAM-Centre for Environmental and Marine Studies, Department of Chemistry, University of Aveiro, Santiago University Campus, 3810-193 Aveiro, Portugal.; Mass Spectrometry Centre, LAQV-REQUIMTE, Department of Chemistry, University of Aveiro, Santiago University Campus, 3810-193 Aveiro, Portugal., Conde T; CESAM-Centre for Environmental and Marine Studies, Department of Chemistry, University of Aveiro, Santiago University Campus, 3810-193 Aveiro, Portugal.; Mass Spectrometry Centre, LAQV-REQUIMTE, Department of Chemistry, University of Aveiro, Santiago University Campus, 3810-193 Aveiro, Portugal., Melo T; CESAM-Centre for Environmental and Marine Studies, Department of Chemistry, University of Aveiro, Santiago University Campus, 3810-193 Aveiro, Portugal.; Mass Spectrometry Centre, LAQV-REQUIMTE, Department of Chemistry, University of Aveiro, Santiago University Campus, 3810-193 Aveiro, Portugal., Silva J; Allmicroalgae Natural Products S.A., R&D Department, Rua 25 de Abril 19, 2445-287 Pataias, Portugal., Abreu MH; ALGAplus-Production and Trading of Seaweed and Derived Products Ltd., 3830-196 Ílhavo, Portugal., Domingues P; Mass Spectrometry Centre, LAQV-REQUIMTE, Department of Chemistry, University of Aveiro, Santiago University Campus, 3810-193 Aveiro, Portugal., Domingues MR; CESAM-Centre for Environmental and Marine Studies, Department of Chemistry, University of Aveiro, Santiago University Campus, 3810-193 Aveiro, Portugal.; Mass Spectrometry Centre, LAQV-REQUIMTE, Department of Chemistry, University of Aveiro, Santiago University Campus, 3810-193 Aveiro, Portugal.
Publikováno v:
Life (Basel, Switzerland) [Life (Basel)] 2023 Jan 13; Vol. 13 (1). Date of Electronic Publication: 2023 Jan 13.
Publikováno v:
IEEE reviews in biomedical engineering [IEEE Rev Biomed Eng] 2023; Vol. 16, pp. 192-207. Date of Electronic Publication: 2023 Jan 05.